FDA approves Boostrix to prevent three diseases in older people

Share this article:
FDA approves Boostrix to prevent three diseases in older people
FDA approves Boostrix to prevent three diseases in older people

The Food and Drug Administration has approved the Boostrix vaccine for the treatment of  tetanus, diphtheria and pertussis (whooping cough) in people ages 65 and older. Boostrix is the first vaccine approved to prevent all three diseases in older people.

“Pertussis is a highly contagious disease and outbreaks have occurred among the elderly in nursing homes and hospitals,” said Karen Midthun, M.D., director of FDA's Center for Biologics Evaluation and Research


Share this article: